Independent Director · Adaptimmune Therapeutics PLC (ADAP)

Garry Menzel director compensation at Adaptimmune (FY2024): $145K

Fiscal year 2024 director compensation for Garry Menzel at Adaptimmune Therapeutics PLC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 25, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Garry Menzel’s full pay file as a PDF — free

More than this page: up to 10 years of Garry’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Garry Menzel and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Adaptimmune Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as Adaptimmune Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$0$0$144,659$0$144,659
FY2023$0—$117,293—$117,293

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Adaptimmune Therapeutics PLC DEF 14A filed April 25, 2025, accession 0001104659-25-039042, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Adaptimmune Therapeutics PLC filed document, accession 0001104659-25-039042. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

Get the Adaptimmune Therapeutics Board Governance Report

$144,659 Garry Menzel, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 25, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

Adaptimmune Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2024 · as the proxy prints them

Audit

The rest of the Adaptimmune Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Adrian RawcliffeDirector—
Ali BehbahaniIndependent Director$152,086
Andrew AllenIndependent Director$140,123
David M. MottChair of the Board$204,195
John FureyIndependent Director$142,623
Kristen HegeIndependent Director$141,524
Lawrence M. AllevaIndependent Director$156,566
Priti HegdeIndependent Director$173,886

The full Adaptimmune Therapeutics compensation record

free company brief

This page is one director within Adaptimmune Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Adaptimmune Therapeutics proxy · each links to its own free brief

Order ADAP

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report